Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

The symptoms, who is at risk, and what every patient on SGLT-2 inhibitors can do right now.
What happens when these two unique drugs are taken together?
How a single change at the FDA could lead to major improvements for patients and the healthcare system.
Lilly announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime...
Sanofi and MannKind announce Afrezza's official US launch.
How these two FDA-submitted drugs could address this major healthcare need.
Kicking off this weekend, what are we most excited about for this year’s ADA?
How a major research study is challenging an outdated FDA restriction.
What this dramatic movement in obesity therapy means for patients in Europe.
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
How this “disease interception” strategy could transform our knowledge of type 1 diabetes.
Dr. Doug Melton and colleagues at the Harvard Stem Cell Institute recently announced new partnerships with Novartis and AstraZeneca to advance stem cell research for...
One of the biggest drug highlights at the 2015 ADA Scientific Sessions was a compelling presentation by diaTribe scientific Advisory Board member Dr. John Buse on brand...
First-ever SGLT-2/DPP-4 inhibitor drug, will this combination cut costs for patients?
What were the risks and benefits of this drug?
What a ride! This year the American Diabetes Association’s (ADA) 75 th Scientific Sessions included groundbreaking clinical trial results, the latest updates on diabetes...
TZD drug pioglitazone becomes second-ever diabetes drug to reduce heart disease and first to reduce strokes. Who might this benefit most?
Combining metformin and Jardiance into a single pill.
Will this drug be cheaper than Lantus and other insulins?
What did four diabetes experts say was the most promising future innovation in diabetes?

Pages